TrialCancer research and treatment2025

A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2- Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response.

Qing Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.